Publications
2023
Myers S. H., Poppi L., Rinaldi F., Veronesi M., Ciamarone A., Previtali V., Bagnolini G., Schipani F., Ortega Martínez J. A., Girotto S., Di Stefano G., Farabegoli F., Walsh N., De Franco F., Roberti M., Cavalli A.
An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer
European Journal of Medicinal Chemistry
2023
Demuro S., Di Martino R.M.C., Sauvey C., Tripathi S.K., Ortega J. A., Russo D., Penna I., Myers S. H., Bandiera T., Girotto S., Abagyan R., Cavalli A.
Design and synthesis of triple protein kinase inhibitors: paving the way towards novel CNS tools to reverse the aberrant tau phosphorylation
ACS Spring 2023 meeting
Poster
Conference
2023
Brindani N., Vuong L.M., Acquistapace I.M., La Serra M.A., Ortega J.A., Veronesi M., Bertozzi S.M., Summa M., Girotto S., Bertorelli R., Armirotti A., Ganesan A.K., De Vivo M.
Design, Synthesis, In Vitro and In Vivo Characterization of CDC42 GTPase Interaction Inhibitors for the Treatment of Cancer
Journal of Medicinal Chemistry
2023
Anselmi M., Bellina F., Quaia R., Panosetti M., Veronesi M., Girotto S., Bertozzi F., Duca M., Bandiera T.
DISCOVERY OF SMALL-MOLECULE INHIBITORS OF MICRORNA-21 BIOGENESIS
IX EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry
Poster
Conference
2023
Rinaldi F., Bernetti M., Bresciani V., Girotto S., Cavalli A.
Dissecting the BRCA2 - RAD51 interaction by integrating computational and experimental biophysics
EMBO Practical Course Integrative modelling of protein interactions
Poster
Conference
2023
Balboni B., Masi M., Rocchia W., Girotto S., Cavalli A.
GSK-3β Allosteric Inhibition: A Dead End or a New Pharmacological Frontier?
International Journal of Molecular Science, vol. 24, (no. 8), pp. 7541
2023
Veronesi M., Bertozzi F., Panosetti M., Bellina F., Quaia R., Anselmi M., Girotto S., Duca M., Bandiera T.
IDENTIFICATION OF BINDERS TO PRE-MIR-21 BY 19F-NMR FRAGMENT-BASED LEAD DISCOVERY
XXVIII National Meeting on Medicinal Chemistry
Poster
Conference
2023
Brusa I., Sondo E., Pesce E., Tomati V., Gioia D., Falchi F., Balboni B., Ortega Martínez J.A., Veronesi M., Romeo E., Margaroli N., Recanatini M., Girotto S., Pedemonte N., Roberti M., Cavalli A.
Innovative Strategy toward Mutant CFTR Rescue in Cystic Fibrosis: Design and Synthesis of Thiadiazole Inhibitors of the E3 Ligase RNF5
Journal of Medicinal Chemistry, vol. 66, (no. 14), pp. 9797-9822
2023
Rinaldi F., Schipani F., Balboni B., Catalano F., Marotta R., Myers S.H., Previtali V., Veronesi M., Scietti L., Cecatiello V., Pasqualato S., Ortega J.A., Girotto S., Cavalli A.
Isolation and Characterization of Monomeric Human RAD51: A Novel Tool for Investigating Homologous Recombination in Cancer
Angewandte Chemie - International Edition
2023
Balboni B., Rinaldi F., Previtali V., Ciamarone A., Girotto S., Cavalli A.
Novel Insights into RAD52’s Structure, Function, and Druggability for Synthetic Lethality and Innovative Anticancer Therapies
Cancers, vol. 15, (no. 6)
2023
Balboni B., Marotta R., Rinaldi F., Girotto S., Cavalli A.
Novel structural insights on full-length human RAD52: Cryo-EM and beyond
bioRxiv
Article
Journal
2023
Romeo E., Saccoliti F., Laselva O., Falchi F., Liessi N., Pastorino C., Armirotti A., Girotto S., Pedemonte N., Bandiera T., Bertozzi F.
Photo-Affinity Labeling (PAL) as a suited approach to investigate the mechanism of action of CFTR corrector ARN23765
18th ECFS Basic Science Conference
Poster
Conference
2023
Tolardo V., Romaldini A., Fumagalli F., Armirotti A., Veronesi M., Magri D., Sabella S., Athanassiou A., Fragouli D.
Polycarbonate nanoplastics and the in vitro assessment of their toxicological impact on liver functionality
Environmental Science: Nano
2022
Dalvit C., Veronesi M., Vulpetti A.
1H and 19F NMR chemical shifts for hydrogen bond strength determination: Correlations between experimental and computed values
Journal of Magnetic Resonance, vol. 12-13, pp. 100070
2022
Demuro S., Sauvey C., Tripathi S.K., Di Martino R.M.C., Shi D., Ortega J.A., Russo D., Balboni B., Giabbai B., Storici P., Girotto S., Abagyan R., Cavalli A.
ARN25068, a versatile starting point towards triple GSK-3β/FYN/DYRK1A inhibitors to tackle tau-related neurological disorders
European Journal of Medicinal Chemistry, vol. 229